EDGAR Filing Documents for 0001193125-22-207645

Form 8-K - Current report:

SEC Accession No. 0001193125-22-207645

Filing Date

2022-08-01

Accepted

2022-08-01 06:55:33

Documents

Period of Report

2022-07-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d356180d8k.htm iXBRL	8-K	43790
2	EX-3.1	d356180dex31.htm	EX-3.1	95252
3	EX-3.2	d356180dex32.htm	EX-3.2	4700
4	EX-10.1	d356180dex101.htm	EX-10.1	166129
5	EX-10.2	d356180dex102.htm	EX-10.2	182368
6	EX-10.3	d356180dex103.htm	EX-10.3	31637
7	EX-99.1	d356180dex991.htm	EX-99.1	11734
11	GRAPHIC	g356180g0801081355834.jpg	GRAPHIC	3881
	Complete submission text file	0001193125-22-207645.txt		816153

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	txmd-20220729.xsd	EX-101.SCH	2877
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	txmd-20220729_lab.xml	EX-101.LAB	18739
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	txmd-20220729_pre.xml	EX-101.PRE	11721
13	EXTRACTED XBRL INSTANCE DOCUMENT	d356180d8k_htm.xml	XML	3554

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431

Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900

TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)